Published: 5/28/2021 9:50:19 AM

Respiratorius Q1 Review - Redeye

Redeye leaves a comment on Respiratorius following the release of the company’s report for the first quarter. We reiterate our Base case of SEK 2,8 and retain our positive stance on the company.

Link to the analysis

Read more about Respiratorius AB